BOIMMG

1-(10Z,13Z,16Z-docosatrienoyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

BOIMMG ID - 257615

Name - 1-(10Z,13Z,16Z-docosatrienoyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

SMILES - CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)O[C@H](COC(=O)CCCCCCCC/C=C\C/C=C\C/C=C\CCCCC)COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@H]1O

InChIKey - YSHTZINQMPFHIJ-PRDIDJHGSA-G

Formula - C51H81O22P4

Annotated - ✔

SWISS LIPIDS id - SLM:000439099

+Structural Parent

+Precursors

+Components

Lipid name	Formula	BOIMMG ID	Listed
1-(10Z,13Z,16Z-docosatrienoyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4,5-bisphosphate	C51H82O19P3	283050	✔
1-(10Z,13Z,16Z-docosatrienoyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4-phosphate	C51H83O16P2	259302	✔
1-(10Z,13Z,16Z-docosatrienoyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-sn-glycero-3-phospho-1D-myo-inositol	C51H84O13P	1472	✔
CDP-1-(10Z,13Z,16Z-docosatrienoyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-sn-glycerol	C54H85N3O15P2	551800	✔
1-(10Z,13Z,16Z-docosatrienoyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3-phosphate	C51H83O16P2	285791	✔
1-(10Z,13Z,16Z-docosatrienoyl)-2-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-sn-glycero-3-phosphate	C45H73O8P	9896	✔
Acyl-ACP ((8Z,11Z,14Z,17Z)-eicosatetraenoate)	C20H31OSR1	749035	✗
(8Z,11Z,14Z,17Z)-eicosatetraenoyl-CoA	C41H62N7O17P3S	397	✔
1-(10Z,13Z,16Z-docosatrienoyl)-sn-glycero-3-phosphate	C25H43O7P	6801	✔
Acyl-ACP ((10Z,13Z,16Z)-docosatrienoate)	C22H37OSR1	749047	✗
Acyl-Phosphates ((10Z,13Z,16Z)-docosatrienoate)	C22H39O5P	738780	✗